Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin

Recurrence of Clostridium difficile infection (CDI) occurs in approximately 25% of successfully treated patients. Two phase 3 randomized, double-blind trials were conducted at 154 sites in the United States, Canada, and Europe to compare fidaxomicin vs vancomycin in treating CDI. Patients with CDI r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cornely, Oliver A., Miller, Mark A., Louie, Thomas J., Crook, Derrick W., Gorbach, Sherwood L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2012
Soggetti:
Supplement Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388030/
https://ncbi.nlm.nih.gov/pubmed/22752865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis462
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi